A detailed history of Pendal Group LTD transactions in Zoetis Inc. stock. As of the latest transaction made, Pendal Group LTD holds 5,168 shares of ZTS stock, worth $914,529. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,168
Previous 5,811 11.07%
Holding current value
$914,529
Previous $861,000 12.08%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 19, 2023

SELL
$131.14 - $157.47 $84,323 - $101,253
-643 Reduced 11.07%
5,168 $0
Q3 2022

Oct 18, 2022

BUY
$148.29 - $182.55 $588,859 - $724,906
3,971 Added 215.82%
5,811 $861,000
Q2 2022

Jul 25, 2022

SELL
$155.97 - $200.09 $24,643 - $31,614
-158 Reduced 7.91%
1,840 $316,000
Q1 2022

Apr 25, 2022

SELL
$181.39 - $234.03 $1,813 - $2,340
-10 Reduced 0.5%
1,998 $377,000
Q4 2021

Jan 18, 2022

SELL
$193.69 - $247.03 $462,144 - $589,413
-2,386 Reduced 54.3%
2,008 $490,000
Q3 2021

Nov 05, 2021

BUY
$189.29 - $209.69 $291,506 - $322,922
1,540 Added 53.96%
4,394 $853,000
Q2 2021

Jul 28, 2021

BUY
$155.9 - $187.99 $77,326 - $93,243
496 Added 21.03%
2,854 $532,000
Q1 2021

May 24, 2021

BUY
$144.0 - $169.39 $339,552 - $399,421
2,358 New
2,358 $371,000
Q1 2021

May 03, 2021

SELL
$144.0 - $169.39 $250,704 - $294,907
-1,741 Closed
0 $0
Q4 2020

Jan 21, 2021

BUY
$157.07 - $174.35 $2,984 - $3,312
19 Added 1.1%
1,741 $288,000
Q3 2020

Nov 02, 2020

SELL
$137.1 - $165.37 $80,614 - $97,237
-588 Reduced 25.45%
1,722 $285,000
Q2 2020

Aug 07, 2020

SELL
$111.92 - $142.53 $281,366 - $358,320
-2,514 Reduced 52.11%
2,310 $317,000
Q1 2020

May 04, 2020

SELL
$92.66 - $144.94 $119,531 - $186,972
-1,290 Reduced 21.1%
4,824 $567,000
Q4 2019

Feb 06, 2020

BUY
$116.25 - $133.25 $127,758 - $146,441
1,099 Added 21.91%
6,114 $809,000
Q3 2019

Nov 12, 2019

SELL
$112.57 - $128.43 $44,915 - $51,243
-399 Reduced 7.37%
5,015 $624,000
Q2 2019

Aug 01, 2019

SELL
$97.98 - $114.28 $2.11 Million - $2.46 Million
-21,569 Reduced 79.94%
5,414 $0
Q1 2019

May 01, 2019

SELL
$81.56 - $100.67 $7,829 - $9,664
-96 Reduced 0.35%
26,983 $0
Q4 2018

Jan 30, 2019

SELL
$79.28 - $95.27 $1,982 - $2,381
-25 Reduced 0.09%
27,079 $2.32 Million
Q3 2018

Nov 05, 2018

SELL
$83.5 - $93.23 $4.12 Million - $4.6 Million
-49,374 Reduced 64.56%
27,104 $0
Q2 2018

Jul 18, 2018

BUY
$79.9 - $89.2 $2.6 Million - $2.9 Million
32,560 Added 74.14%
76,478 $0
Q1 2018

May 08, 2018

BUY
$71.51 - $84.69 $2.55 Million - $3.02 Million
35,620 Added 429.26%
43,918 $0
Q4 2017

Feb 06, 2018

SELL
$63.24 - $72.8 $87,777 - $101,046
-1,388 Reduced 14.33%
8,298 $0
Q3 2017

Nov 01, 2017

BUY
$59.73 - $65.4 $37,988 - $41,594
636 Added 7.03%
9,686 $0
Q2 2017

Aug 11, 2017

BUY
N/A
9,050
9,050 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.